Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 2/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9318505 | 1.00 | ALDH1A1 (0.43) | ALDH1A1CYP4F2CYP4A11ATMCA2 | |
| SCHEMBL9318736 | 1.00 | ALDH1A1 (0.43) | ALDH1A1CYP4F2CYP4A11ATMCA2 | |
| Hydrochloric Acid SCHEMBL9687274 | 0.98 | ALDH1A1 (0.41) | ALDH1A1CYP4F2CYP4A11ATMCA2 | |
| Ethylene Glycol SCHEMBL3728618 | 0.94 | TSHR (0.40) | ALDH1A1CYP4F2CYP4A11ATMCA2 | |
| SCHEMBL3799107 | 0.93 | DNM1 (0.45) | ACE2HCAR2TP53TSHRGPR84 | |
| SCHEMBL8665961 | 0.93 | DNM1 (0.45) | ACE2HCAR2TP53TSHRGPR84 | |
| 1,4-Butanediol SCHEMBL3738766 | 0.92 | SMN1; SMN2 (0.41) | ALDH1A1CYP4F2CYP4A11TSHRPPARG | |
| SCHEMBL6580840 | 0.91 | DNM1 (0.48) | ACE2HCAR2TP53TSHRGPR84 | |
| SCHEMBL9508153 | 0.91 | DNM1 (0.48) | ACE2HCAR2TP53TSHRGPR84 | |
| SCHEMBL7784786 | 0.91 | DNM1 (0.48) | ACE2HCAR2TP53TSHRGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 293 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106905155-B | Method for generating butyl acrylate by cracking butyl acrylate heavy component | 万华化学集团股份有限公司 | 2020-04-10 | — | — | CN | claimed |
| US-8277698-B2 | Infrared curable ink composition for color filter and color filter | LG CHEM, LTD. (KR) | 2012-10-02 | — | — | US | claimed |
| US-20110005427-A1 | INFRARED CURABLE INK COMPOSITION FOR COLOR FILTER AND COLOR FILTER | LG CHEM, LTD. (KR) | 2011-01-13 | — | — | US | claimed |
| US-20070238669-A1 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS | BRISTOL-MYERS SQUIBB COMPANY | 2007-10-11 | — | — | US | claimed |
| EP-1497405-B1 | COMPOSITION COMPRISING A MIXTURE OF ALKYL MONO AND POLYLACTYLLACTATE | ARKEMA FRANCE (FR) | 2006-10-04 | — | — | EP | claimed |
| EP-1497405-A1 | COMPOSITION COMPRISING A MIXTURE OF ALKYL MONO AND POLYLACTYLLACTATE | ARKEMA (FR) | 2005-01-19 | — | — | EP | claimed |
| WO-2003087284-A1 | COMPOSITION COMPRISING A MIXTURE OF ALKYL MONO AND POLYLACTYLLACTATE | ATOFINA (FR) | 2003-10-23 | — | — | WO | claimed |
| CN-1352639-A | Novel tricyclic compounds and their use in medicine, process for their production and pharmaceutical composition containing them | REDDY RESEARCH FOUNDATION (IN) | 2002-06-05 | — | — | CN | claimed |
| EP-0260910-B1 | 3,6-DIPHENYLPYRIDAZINES | Chisso Corporation (JP) | 1992-05-27 | — | — | EP | claimed |
| EP-0175591-A2 | Lactic acid derivative, liquid crystal composition containing same and liquid crystal device | CANON KABUSHIKI KAISHA (JP) | 1986-03-26 | — | — | EP | claimed |
| JP-3263483-A | — | — | None | — | — | JP | disclosed |
| JP-9124551-A | — | — | None | — | — | JP | disclosed |
| EP-4727910-A1 | PROCESS FOR PURIFYING LIGHT ACRYLATES | ARKEMA France (FR) | 2026-04-22 | — | — | EP | disclosed |
| EP-4392399-B1 | IMPROVED METHOD FOR PRODUCING HIGH-PURITY BUTYL ACRYLATE | ARKEMA FRANCE (FR) | 2026-01-14 | — | — | EP | disclosed |
| US-12516201-B2 | Aqueous coating composition for dipcoating electrically conductive substrates containing bismuth and lithium | BASF COATINGS GMBH (DE) | 2026-01-06 | — | — | US | disclosed |
| EP-0281424-A1 | Optically active compounds having a plurality of asymmetric carbon atoms | CHISSO CORPORATION (JP) | 1988-09-07 | — | — | EP | disclosed |
| EP-0279629-A2 | 1,2-Propanediol derivatives | Chisso Corporation (JP) | 1988-08-24 | — | — | EP | disclosed |
| EP-0260910-A1 | 3,6-Diphenylpyridazines | Chisso Corporation (JP) | 1988-03-23 | — | — | EP | disclosed |
| EP-0187297-A2 | Alkoxy methyl ether and alkoxy methyl ester derivatives | SYNTEX (U.S.A.) INC. (US) | 1986-07-16 | — | — | EP | disclosed |
| EP-0175591-A2 | Lactic acid derivative, liquid crystal composition containing same and liquid crystal device | CANON KABUSHIKI KAISHA (JP) | 1986-03-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238669-A1 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS | GLP1R, GIPR, IAPP | ALDH1A1 4570/4885CYP4F2 2732/4885CYP4A11 1797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.